Scholarlink

Background <p>Variants in the <i>FBXO7</i> gene are a recognized cause of juvenile-onset autosomal recessive parkinsonism (PARK15) with a heterogeneous phenotype. There is limited number of reported cases in the literature.</p> Objective <p>To report a 19-year-old Indian man with juvenile-onset parkinsonism harbouring a novel <i>FBXO7</i> variant and to review the published literature on <i>FBXO7</i>-associated parkinsonism/parkinsonism-pyramidal syndrome, focusing on the clinical, imaging, and genetic spectrum and possible genotype–phenotype correlations.</p> Methods <p>We evaluated an Indian male with <i>FBXO7</i>-associated juvenile parkinsonism and reviewed previously published cases from the literature to assess the clinical, imaging, and genetic spectrum.</p> Results <p>A total of 32 cases of <i>FBXO7</i>-associated parkinsonism, including our patient, were identified. The median age at onset was 17 years, median age at presentation was 28 years, with slight male predominance and a median disease duration of 5 years. Symmetrical juvenile-onset parkinsonism with tremor and postural instability was the commonest presentation. Dementia, dystonia, pyramidal signs, and gaze abnormalities were less frequent associated features. Most patients showed levodopa responsiveness, although motor complications and psychiatric adverse effects were common. Neuroimaging findings were heterogeneous, ranging from cortical atrophy to pallidal hypointensity and presynaptic dopaminergic deficits on dopamine transporter imaging. Twenty variants were identified, with the homozygous nonsense variant c.1492&#xa0;C &gt; T (p.Arg498*) being the most frequently reported.</p> Conclusion <p><i>FBXO7</i>-associated parkinsonism typically presents as symmetrical juvenile-onset levodopa-responsive parkinsonism, although early-onset parkinsonism is known. Dementia, dystonia, and pyramidal signs are less frequent associated features. <i>FBXO7</i> variants should be considered in patients with symmetrical juvenile/early-onset parkinsonism, especially when accompanied by levodopa-induced psychiatric adverse effects.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

FBXO7- associated parkinsonism: clinical, genetic, and radiological insights from a case report and literature review

  • 期刊论文

  • 发表日期：

    2026年6月29日

查看全文
  • Rohan R. Mahale,
  • Pramod Khanda,
  • Subhajit Roy

摘要

Background

Variants in the FBXO7 gene are a recognized cause of juvenile-onset autosomal recessive parkinsonism (PARK15) with a heterogeneous phenotype. There is limited number of reported cases in the literature.

Objective

To report a 19-year-old Indian man with juvenile-onset parkinsonism harbouring a novel FBXO7 variant and to review the published literature on FBXO7-associated parkinsonism/parkinsonism-pyramidal syndrome, focusing on the clinical, imaging, and genetic spectrum and possible genotype–phenotype correlations.

Methods

We evaluated an Indian male with FBXO7-associated juvenile parkinsonism and reviewed previously published cases from the literature to assess the clinical, imaging, and genetic spectrum.

Results

A total of 32 cases of FBXO7-associated parkinsonism, including our patient, were identified. The median age at onset was 17 years, median age at presentation was 28 years, with slight male predominance and a median disease duration of 5 years. Symmetrical juvenile-onset parkinsonism with tremor and postural instability was the commonest presentation. Dementia, dystonia, pyramidal signs, and gaze abnormalities were less frequent associated features. Most patients showed levodopa responsiveness, although motor complications and psychiatric adverse effects were common. Neuroimaging findings were heterogeneous, ranging from cortical atrophy to pallidal hypointensity and presynaptic dopaminergic deficits on dopamine transporter imaging. Twenty variants were identified, with the homozygous nonsense variant c.1492 C > T (p.Arg498*) being the most frequently reported.

Conclusion

FBXO7-associated parkinsonism typically presents as symmetrical juvenile-onset levodopa-responsive parkinsonism, although early-onset parkinsonism is known. Dementia, dystonia, and pyramidal signs are less frequent associated features. FBXO7 variants should be considered in patients with symmetrical juvenile/early-onset parkinsonism, especially when accompanied by levodopa-induced psychiatric adverse effects.